Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Randomized, Placebo-controlled, Multicentre, Relapse-prevention Study of Vortioxetine in Paediatric Patients Aged 7 to 11 Years With Major Depressive Disorder

NCT05014919 is registered in ClinicalTrials.gov with H. Lundbeck A/S as lead sponsor.

NCT NCT05014919
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05014919 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Randomized, Placebo-controlled, Multicentre, Relapse-prevention Study of Vortioxetine in Paediatric Patients Aged 7 to 11 Years With Major Depressive Disorder
Lead sponsor
H. Lundbeck A/S
Phase
Phase 3
Overall status
Terminated
Start date
August 10, 2021
Completion date
April 28, 2022
Enrollment
35 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

depression